The short-term effects of chondroitin sulfates A and C on coronary atherosclerotic subjects: With reference to its anti-thrombogenic activities.
D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy; D001777:Blood Coagulation / Q000187:drug effects; D002645:Chickens; D002807:Chondroitin / Q000008:administration & dosage / Q000627:therapeutic use*; D003327:Coronary Disease / Q000188:drug therapy*; D004562:Electrocardiography; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D000882:Haplorhini; D006801:Humans; D007275:Injections, Intravenous; D011517:Prothrombin Time; D011817:Rabbits; D013431:Sulfates / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D013431:Sulfates; D002807:Chondroitin